You are on page 1of 2

Volume 8, Issue 2, February – 2023 International Journal of Innovative Science and Research Technology

ISSN No:-2456-2165

Assessment of Efficacy of Midazolam as an


Adjuvant to Intrathecal Bupivacaine for Lower
Abdominal Surgeries
Dr. Kottam Surekha. Post Graduate, Dr. Shaik Mohammed Ghiyazuddin, Assistant professor,
Department of Anesthesiology, Kurnool Medical College Department of Anesthesiology, Kurnool medical college
Kurnool, Andhra Pradesh. Kurnool, Andhra Pradesh.

I. INTRODUCTION

Spinal anaesthesia is the most commonly used regional


anaesthetic technique. Local anaesthetic agents used for this
purpose provide good intraoperative analgesia. However,
they provide a very limited postoperative duration of action.
In order to overcome this problem and to maximise the
duration of anaesthesia-analgesia, many adjuvants, such as
intrathecal opioids and non-opioids, have increasingly been
tried in the last two decades to relieve postoperative pain.

 Aims & Objectives


Bupivacaine when used alone produces analgesia for
2.5 to 3 hours, making it unsuitable in cases where the
duration of surgery is longer and in cases which require
further analgesia during post-operative period. Present study
is intended to evaluate the effect of addition of intrathecal
midazolam to bupivacaine to prolong the post-operative
analgesia.

II. METHODOLOGY Fig 2 Summary Results

A prospective randomized double-blind study was Both groups did not differ significantly as regard to
carried out on 60 adult ASA gr 1 and 2 pts, to compare the time of onset of sensory block, duration of action, time for
efficacy of intrathecal bupivacaine with midazolam and regression of sensory block to T12. There was significant
bupivacaine alone for post operative pain relief. Pts were duration of post operative analgesia observed in group BM.
randomly divided into 2 groups. Group B {n=30} received There were no episodes of bradycardia, hypotension,
3ml of 0.5% bupivacaine with 0.2 ml of 0.9% normal saline. sedation, intraoperatively or postoperatively and no
Group BM{n=30} received 3ml of 0.5% bupivacaine with vomiting, pruritis and urinary retention in post operative
0.2 ml of preservative free midazolam. period.

III. DISCUSSION

Our study shows that the addition of midazolam to


intrathecal bupivacaine significantly prolongs the duration
of postoperative analgesia. The time to first rescue analgesic
was more than 16 hrs in BM group as compared to 3.5 hrs in
B group. Antinociceptive action are mediated via
BZD/GABA-A receptor complex which are present in
lamina 2 of dorsal horn ganglia of spinal cord Intrathecal
midazolam probably causes release of an endogenous opioid
acting at spinal delta receptors as naltrindole. Intrathecal
midazolam besides causing analgesia has also been found to
be effective in suppressing reflex response to visceral
distention and its pain. Intrathecal midazolam has been
shown to be free of any neurotoxicity and other side effects
Fig 1 Demographic Profile Chart with dose up to 2mg.

IJISRT23FEB379 www.ijisrt.com 586


Volume 8, Issue 2, February – 2023 International Journal of Innovative Science and Research Technology
ISSN No:-2456-2165
IV. CONCLUSION

Intrathecal midazolam added to bupivacaine prolongs


duration of post op analgesia without prolonging the
duration of dermatomal sensory block with no side effects.

REFERENCES

[1]. Valentine MJ, lyons G bellemy MC.the effect of


intrathecal midazolam on post op pain. j of
anaesthesia 1996 13:589-593.
[2]. Edwards m, Serrao. mechanism by which midazolam
causes spinally mediated analgesia. anaesthesiology
1990-73,273,77.
[3]. Indian j, anaesthesia 2005; 49(1);37-39 effect of
intrathecal midazolam bupivacaine combination on
post op analgesia.

IJISRT23FEB379 www.ijisrt.com 587

You might also like